文献速递功能神经外科神经创伤

耐药性创伤后癫痫切除术的发作结局预测因素

Resective surgery for drug-resistant posttraumatic epilepsy: predictors of seizure outcome.
PubMed 文献 · J Neurosurg · 2019-10-04

该研究回顾性分析了2008至2016年间在首都医科大学三博脑科医院接受切除术的90例耐药性创伤后癫痫患者,随访2至10年。结果显示70%患者无发作,仅癫痫病程≤8年是良好结局的独立预测因素,提示早期手术可能获益更多。

要点

  • 耐药性创伤后癫痫切除术可使70%患者达到无发作。
  • 癫痫病程≤8年是良好发作结局的独立预测因素。
  • 永久性神经功能缺损发生率为11.1%。

核心结论

  • 切除术是耐药性创伤后癫痫的有效治疗,并发症发生率可接受。
  • 癫痫病程≤8年是良好发作结局的独立预测因素,提示早期手术可能带来更多获益。

研究设计与样本

  • 共90例患者,随访2至10年(均值±标准差5.79±2.84年)。
  • 采用ILAE分类评估发作结局,ILAE 1级和2级定义为良好结局。
  • 采用单因素分析和多因素logistic回归(后退法)识别预测因素。

主要发现

  • 70%(63例)患者无发作,其中68.9%(62例)为ILAE 1级,1.1%(1例)为ILAE 2级。
  • 10例(11.1%)出现永久性神经功能缺损。
  • 单因素和多因素分析显示,仅癫痫病程≤8年是良好发作结局的独立预测因素(OR 0.34,95% CI 0.13-0.92)。

关键数值与推荐

  • 良好结局定义为随访最后2年ILAE 1级或2级。
  • 癫痫病程≤8年为良好结局的独立预测因素(OR 0.34,95% CI 0.13-0.92)。

临床怎么用

  • 对耐药性创伤后癫痫患者,切除术是有效治疗选择,应评估手术获益与11.1%永久性神经功能缺损风险。
  • 癫痫病程≤8年的患者可能从早期手术中获益更多,应尽早考虑手术评估。

局限性

  • 回顾性单中心研究,样本量90例,可能存在选择偏倚。
  • 随访时间2至10年不等,结局评估时间点不完全一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The object of this study was to evaluate surgical outcomes and prognosis factors in patients with drug-resistant posttraumatic epilepsy (PTE) who had undergone resective surgery. METHODS: The authors retrospectively reviewed the records of all patients with drug-resistant PTE who had undergone resective surgery at Sanbo Brain Hospital, Capital Medical University, in the period from January 2008 to December 2016. All patients had a follow-up period of at least 2 years. Seizure outcomes were evaluated according to the International League Against Epilepsy (ILAE) classification. Patients in ILAE classes 1 and 2 during the last 2 years of follow-up were classified as having a favorable outcome; patients in all other classes were considered to have an unfavorable outcome. Univariate analysis and a multivariate logistic regression model in a backward fashion were used to identify the potential predictors of seizure outcomes. RESULTS: Among 90 patients with a follow-up of 2-10 years (mean ± standard deviation, 5.79 ± 2.84 years), 70% (63 patients) were seizure free, of whom 68.9% (62 patients) had an ILAE class 1 outcome and 1.1% (1 patient) had an ILAE class 2 outcome. Permanent neurological deficits were observed in 10 patients (11.1%). Univariate and multivariate analyses revealed that only the duration of seizures ≤ 8 years was an independent predictor of a favorable seizure outcome (OR 0.34, 95% CI 0.13-0.92). CONCLUSIONS: Resective surgery is an effective treatment for patients with drug-resistant PTE with an acceptable incidence of complications. The information on prognosis factors suggests that early surgery may offer more benefits to patients with drug-resistant PTE.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. He X, Guan Y, Zhai F, et al. Resective surgery for drug-resistant posttraumatic epilepsy: predictors of seizure outcome. J Neurosurg. 2019. PMID: 31585428. doi:10.3171/2019.7.JNS191233

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。